MICROSOMAL CYTOCHROME P450 IN HUMAN BRAIN-REGIONS

被引:26
|
作者
BHAMRE, S
ANANDATHEERTHAVARADA, HK
SHANKAR, SK
RAVINDRANATH, V
机构
[1] NATL INST MENTAL HLTH & NEUROSCI,DEPT NEUROCHEM,BANGALORE 560029,KARNATAKA,INDIA
[2] NATL INST MENTAL HLTH & NEUROSCI,DEPT NEUROPATHOL,BANGALORE 560029,KARNATAKA,INDIA
关键词
D O I
10.1016/0006-2952(92)90390-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 (P450) levels were quantitated in microsomes from human brain regions obtained at autopsy. The reduced carbon monoxide binding spectra of cortical microsomes showed two absorption maxima at 449 and 425 nm. On solubilization of the microsomes, essentially a single peak was observed at 449 nm. The P450 levels in human brain cortical microsomes varied from 0.03 to 0. 12 nmol/mg protein among the seven samples examined. The concentration of the hemeprotein present as nmol/g tissue was highest in the brain stem and cerebellum and lowest in the striatum and hippocampus.
引用
收藏
页码:1223 / 1225
页数:3
相关论文
共 50 条
  • [41] THE MECHANISM OF THE REDUCTIVE DEHALOGENATION OF POLYHALOGENATED COMPOUNDS BY MICROSOMAL CYTOCHROME P450
    NASTAINCZYK, W
    AHR, H
    ULRICH, V
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1982, 136 : 799 - 808
  • [42] THE INHIBITORY EFFECTS OF GASTROINTESTINAL AND RESPIRATORY DRUGS ON HUMAN HEPATIC MICROSOMAL CYTOCHROME P450 ACTIVITIES
    Iwase, Mariko
    Nishimura, Yuki
    Kurata, Norimitsu
    Tsukurimichi, Atsushi
    Oguchi, Katsuji
    DRUG METABOLISM REVIEWS, 2015, 47 : 113 - 114
  • [43] MICROSOMAL CYTOCHROME P450 ENZYME ACTIVITIES IN NONALCOHOLIC STEATOHEPATITIS LIVERS
    Czerwinski, Maciej
    Oberheide, Brian
    Hatfield, Nicholas
    Ewy, Bill
    Seib, Christopher
    Gatineau, Eva
    Yiannikouris, Frederique
    O'Brien, Molly
    Ogilvie, Brian
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S25 - S25
  • [44] Effects of olopatadine, a new antiallergic agent, on human liver microsomal cytochrome P450 activities
    Kajita, J
    Inano, K
    Fuse, E
    Kuwabara, T
    Kobayashi, H
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (12) : 1504 - 1511
  • [45] Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity
    Guo, LQ
    Taniguchi, M
    Xiao, YQ
    Baba, K
    Ohta, T
    Yamazoe, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 2000, 82 (02): : 122 - 129
  • [46] Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes
    Madan, A
    Graham, RA
    Carroll, KM
    Mudra, DR
    Burton, LA
    Krueger, LA
    Downey, AD
    Czerwinski, M
    Forster, J
    Ribadeneira, MD
    Gan, LS
    Lecluyse, EL
    Zech, K
    Robertson, P
    Koch, P
    Antonian, L
    Wagner, G
    Yu, L
    Parkinson, A
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (04) : 421 - 431
  • [47] In vitro assessment of human cytochrome P450
    Clarke, SE
    XENOBIOTICA, 1998, 28 (12) : 1167 - 1202
  • [48] Human Cytochrome P450 and Personalized Medicine
    Chen, Qi
    Wei, Dongqing
    ADVANCE IN STRUCTURAL BIOINFORMATICS, 2015, 827 : 341 - 351
  • [49] Cytochrome P450
    P. H. Roos
    N. Jakubowski
    Analytical and Bioanalytical Chemistry, 2008, 392 : 1015 - 1017
  • [50] Cytochrome P450
    Roos, P. H.
    Jakubowski, N.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 392 (06) : 1015 - 1017